Filter
421
Text search:
drug
stability
testing
Featured
Recommendations
37
New Publications
111
Language
Document type
No document type
276
Guidelines
54
Studies & Reports
51
Manuals
22
Strategic & Response Plan
9
Situation Updates
3
Fact sheets
3
Training Material
2
Infographics
1
Countries / Regions
India
20
Uganda
14
Kenya
14
Liberia
13
South Africa
12
Nigeria
10
Zambia
10
Tanzania
10
Ethiopia
9
Sierra Leone
8
Malawi
8
Western and Central Europe
8
Global
8
Rwanda
7
Zimbabwe
6
Bangladesh
6
Asia
6
Cambodia
5
Namibia
5
Ukraine
5
Nepal
4
Botswana
4
Eastern Europe
4
Ghana
3
South Sudan
3
Mozambique
3
Middle East and North Africa
3
Guinea
2
Senegal
2
Congo, Democratic Republic of
2
USA
2
Lesotho
2
West and Central Africa
2
South–East Asia Region
2
Latin America and the Carribbean
2
Eastern Europe and Central Asia
2
Africa
2
Russia
2
Burkina Faso
1
Philippines
1
Iraq
1
Syria
1
China
1
Indonesia
1
Malaysia
1
Sudan
1
Colombia
1
Myanmar / Burma
1
Yemen
1
East and Southern Africa
1
Western Pacific Region
1
Albania
1
Moldova
1
Australia
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
170
Clinical Guidelines
40
Pharmacy & Technologies
18
Public Health
13
Women & Child Health
13
Key Resources
10
Capacity Building
6
Toolboxes
HIV
55
Mental Health
33
TB
32
Pharmacy
29
COVID-19
23
AMR
16
Ebola
11
Rapid Response
10
NTDs
10
Caregiver
6
Conflict
4
Planetary Health
4
Health Financing Toolbox
4
Natural Hazards
3
Global Health Education
3
NCDs
3
Refugee
2
Specific Hazards
2
Disability
1
Zika
1
Social Ethics
1
Drug Advisory Board
Rappart sur les populations clés.
Key populations brief.
Краткое руководство
Informe sobre poblaciones clave.
A practical toolkit for young people who are passionate about advancing HIV and sexual and reproductive health and rights through national advocacy in the post-2015 agenda.
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
After completing this activity, pharmacists should be able to:
1. List populations for which the compounding of an oral liquid may be necessary
2. Outline necessary considerations that should be made by the pharmacist to ensure product stability
...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spr
...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are
...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T
...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,
...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a
...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar
...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv
...
